Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;187(1):69-80.
doi: 10.1007/s10549-021-06142-6. Epub 2021 Feb 25.

Overexpression of Stat3 increases circulating cfDNA in breast cancer

Yi-Fei Wang  1   2 , Xue-Jian Wang  1   3 , Zhong Lu  1   2 , Shu-Rong Liu  1   2 , Yu Jiang  1   2 , Xiao-Qing Wan  1 , Cong-Cong Cheng  1   2 , Li-Hong Shi  1   3 , Li-Hua Wang  1   2 , Yi Ding  4   5
Affiliations

Overexpression of Stat3 increases circulating cfDNA in breast cancer

Yi-Fei Wang et al. Breast Cancer Res Treat. 2021 May.

Abstract

Purpose: Current studies on circulating cell-free DNA (cfDNA) have been focusing on its potential as biomarkers in liquid biopsy by detecting its content or genetic and epigenetic changes for the evaluation of tumor burden and therapeutic efficacy. However, the regulatory mechanism of cfDNA release remains unclear. Stat3 has been documented as an oncogene for the development and metastasis of breast cancer cells. In this study, we investigated whether Stat3 affects the release of cfDNA into blood and its association with the number of circulating tumor cells (CTCs).

Methods: The cfDNA level in plasma of patients with breast cancer and healthy volunteers were determined by quantitative real-time PCR. Three mouse breast cancer models with different Stat3 expression were generated and used to established three breast cancer orthotopic animal models to examine the effect of Stat3 on cfDNA release in vivo. Stat3 mediated Epithelial-mesenchymal phenotype transition of CTCs was determined by immunofluorescence assay and Western blot assay.

Results: The data showed that Stat3 increased circulating cfDNA, which is correlated with the increased volume of primary tumors and number of CTCs, accompanied with the dynamic EMT changes regulated by Snail induction. Furthermore, the high level of total circulating cfDNA and Stat3-cfDNA in patients with breast cancer were detected by quantitative real-time PCR using GAPDH and Stat3 primers.

Conclusion: Our results suggested that Stat3 increases the circulating cfDNA and CTCs in breast cancer.

Keywords: Breast cancer; Circulating cell-free DNA (cfDNA); Circulating tumor cells (CTCs); EMT; Stat3.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Schwarzenbach H, Hoon DS, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11:426–437. https://doi.org/10.1038/nrc3066 - DOI - PubMed
    1. Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S, Hoon DS (2006) Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol 24:4270–4276. https://doi.org/10.1200/JCO.2006.05.9493 - DOI - PubMed
    1. Giuliano M, Giordano A, Jackson S, Giorg UD, Mego M, Cohen EN, Gao H, Anfossi S, Handy BC, Ueno NT et al (2014) Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination. Breast Cancer Res Treat 16:440–457. https://doi.org/10.1186/s13058-014-0440-8 - DOI
    1. Snyder MW, Kircher M, Hill AJ, Daza RM, Shendure J (2016) Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin. Cell 164:57–68. https://doi.org/10.1016/j.cell.2015.11.050 - DOI - PubMed - PMC
    1. Madhavan D, Wallwiener M, Bents K, Zucknick M, Nees J, Schott S, Cuk K, Riethdorf S, Trumpp A, Pantel K et al (2014) Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis. Breast Cancer Res Treat 146:163–174. https://doi.org/10.1007/s10549-014-2946-2 - DOI - PubMed

LinkOut - more resources